BUSINESS COMBINATION PROPOSED — YOUR VOTE IS VERY IMPORTANTTransaction Agreement • October 10th, 2024 • Exscientia PLC • Biological products, (no disgnostic substances) • Delaware
The following questions and answers are intended to briefly address some commonly asked questions regarding the Transaction, the Transaction Agreement, the Recursion Special Meeting, and the Exscientia Shareholder Meetings. These questions and answers may not address all questions that may be important to you as a Recursion stockholder or an Exscientia shareholder. Please refer to the section entitled “Summary” beginning on page 19 of this joint proxy statement and the more detailed information contained elsewhere in this joint proxy statement, the annexes to this joint proxy statement and the documents referred to in this joint proxy statement, which you should read carefully and in their entirety. You may obtain the information incorporated by reference into this joint proxy statement without charge by following the instructions under the section entitled “Where You Can Find More Information” beginning on page 197 of this joint proxy statement.
